Nasdaq · Biotech stocks database
AGMB (AgomAb Therapeutics NV) stock: $12.17, $599.3M market cap, $101.5M cash, $497.8M EV, $1.11B fully diluted market cap. Data from Fully Diluted's biotech stocks database.
| Cash | $101.5M |
|---|---|
| Debt | $0.0M |
| Net cash | $101.5M |
| Enterprise value | $497.8M |
| Basic shares | 49.2M shares |
| Fully diluted shares | 91.1M shares |
| Fully diluted market cap | $1,109.3M |
| Cash per share | $2.06 |
Cash figures as of 2025-12-31. Database snapshot: 2026-09-21.
Loading AGMB daily closes…